MRK - Merck & Co., Inc.
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 232.14B |
| Enterprise value 3 | 252.24B |
| Trailing P/E | 25.48 |
| Forward P/E 1 | 16.28 |
| PEG ratio (5-yr expected) 1 | 1.75 |
| Price/sales (ttm) | 5.05 |
| Price/book (mrq) | 8.67 |
| Enterprise value/revenue 3 | 5.49 |
| Enterprise value/EBITDA 6 | 13.95 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.53 |
| 52-week change 3 | 20.65% |
| S&P500 52-week change 3 | 23.16% |
| 52-week high 3 | 92.64 |
| 52-week low 3 | 72.05 |
| 50-day moving average 3 | 89.84 |
| 200-day moving average 3 | 85.46 |
Share statistics
| Avg vol (3-month) 3 | 8.29M |
| Avg vol (10-day) 3 | 9.27M |
| Shares outstanding 5 | 2.55B |
| Float | 2.54B |
| % held by insiders 1 | 0.07% |
| % held by institutions 1 | 77.56% |
| Shares short (30 Dec 2019) 4 | 25.15M |
| Short ratio (30 Dec 2019) 4 | 3.42 |
| Short % of float (30 Dec 2019) 4 | 0.97% |
| Short % of shares outstanding (30 Dec 2019) 4 | 0.99% |
| Shares short (prior month 28 Nov 2019) 4 | 24.67M |
Dividends & splits
| Forward annual dividend rate 4 | 2.44 |
| Forward annual dividend yield 4 | 2.67% |
| Trailing annual dividend rate 3 | 2.13 |
| Trailing annual dividend yield 3 | 2.33% |
| 5-year average dividend yield 4 | 2.99 |
| Payout ratio 4 | 61.45% |
| Dividend date 3 | 07 Jan 2020 |
| Ex-dividend date 4 | 12 Dec 2019 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 16 Feb 1999 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2018 |
| Most-recent quarter (mrq) | 29 Sep 2019 |
Profitability
| Profit margin | 20.26% |
| Operating margin (ttm) | 31.60% |
Management effectiveness
| Return on assets (ttm) | 10.78% |
| Return on equity (ttm) | 30.86% |
Income statement
| Revenue (ttm) | 45.97B |
| Revenue per share (ttm) | 17.80 |
| Quarterly revenue growth (yoy) | 14.90% |
| Gross profit (ttm) | 28.81B |
| EBITDA | 18.08B |
| Net income avi to common (ttm) | 9.31B |
| Diluted EPS (ttm) | 3.58 |
| Quarterly earnings growth (yoy) | -2.50% |
Balance sheet
| Total cash (mrq) | 8.02B |
| Total cash per share (mrq) | 3.15 |
| Total debt (mrq) | 27.11B |
| Total debt/equity (mrq) | 100.69 |
| Current ratio (mrq) | 1.26 |
| Book value per share (mrq) | 10.52 |
Cash flow statement
| Operating cash flow (ttm) | 12.24B |
| Levered free cash flow (ttm) | 9.74B |